Oxynorm Dispersa (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxynorm Dispersa, is an opioid analgesic presented as a strength/form for oral use. It is indicated for the management of moderate to severe pain in adult patients. GNH USA supplies Oxynorm Dispersa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxynorm Dispersa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxynorm Dispersa is an opioid analgesic that acts on the central nervous system to relieve pain. - Acute postoperative pain: provides effective relief following surgical procedures. - Cancer‑related pain: helps control moderate to severe pain associated with malignancies. - Chronic non‑cancer pain: used when other analgesics are insufficient for conditions such as severe osteoarthritis.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea: mild to moderate upset stomach. - Drowsiness: increased sleepiness or sedation. - Dry mouth: decreased salivary flow. - Dizziness: light‑headed sensation. - Itching: mild pruritus.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing. - Severe hypotension: marked drop in blood pressure. - Dependence or addiction: potential for misuse. - Seizures: rare convulsive episodes. - Anaphylaxis: acute allergic reaction. - Adrenal insufficiency: impaired cortisol production.

When prescribing Oxynorm Dispersa, clinicians should consider several safety measures. - Assess pain severity: ensure opioid therapy is appropriate for the level of pain. - Evaluate respiratory function: monitor patients with existing respiratory disorders. - Review medication history: avoid concurrent use with other central nervous system depressants. - Counsel on dependence risk: educate patients about signs of misuse. - Monitor renal and hepatic function: adjust use in impaired organ function. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxynorm Dispersa can interact with a range of medicines, requiring careful management.

Major Interactions (Avoid): - Other opioids: combined use can cause profound respiratory depression. - Benzodiazepines: concurrent use increases sedation and respiratory risk. - CNS depressants: additive effects may lead to excessive drowsiness.

Moderate Interactions (Monitor Closely): - MAO inhibitors: may precipitate hypertensive crisis. - Antidepressants (SSRIs, SNRIs): can increase serotonin levels and risk serotonin syndrome. - Antihistamines: may enhance sedative effects.